ReviewHematology. American Society of Hematology. Education Program2020

Rituximab and eculizumab when treating nonmalignant hematologic disorders: infection risk, immunization recommendations, and antimicrobial prophylaxis needs.

Elissa R Engel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.